- Inspections, surveillance to continue against unauthorised sale, promotion of GLP-1 weight loss drugs: Govt Press Trust of India
- Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details The Times of India
- Indian Government Tightens Surveillance On GLP-1 Weight-Loss Drugs As Generics Flood Market After Semaglutide Patent Expiry Swarajyamag
- ‘Clinical oversight can lead to…’: Govt lists side-effects that can occur from weight-loss drugs Business Today
- As India's weight management market expands, misleading ads risk rises Business Standard
Inspections, surveillance to continue against unauthorised sale, promotion of GLP-1 weight loss drugs: Govt - Press Trust of India
Inspections, surveillance to continue against unauthorised sale, promotion of GLP-1 weight loss drugs: Govt Press Trust of India Government tightens oversight of GLP-1 drugs, flags risks amid rising demand; key details…


